May 26, 2015 — At least 45 lawsuits involving people who took Benicar and developed sprue-like enteropathy have been filed in a federal Multi-District Litigation (MDL No. 2606) since it was created last month.
According to an update (PDF) from the U.S. Judicial Panel on Multidistrict Litigation (JPML), the size of the litigation has nearly tripled since mid-April, when 15 cases were transferred to the MDL from state courts around the nation.
The lawsuits have been centralized in the U.S. District Court for New Jersey under Judge Robert B. Kugler. Members of the litigation accuse Daiichi Sankyo, Inc. and Forest Laboratories of negligence for failing to adequately warn about the risk of sprue-like enteropathy.
Benicar (olmesartan) is a blood pressure drug that was prescribed to 1.9 million patients in 2012, according to court documents. That year, Mayo Clinic Proceedings published a study linking Benicar with nearly two dozen cases of sprue-like enteropathy.
The FDA ordered drug-makers to update the label on Benicar in July 2013. After reviewing adverse events, the FDA also warned that some patients did not develop symptoms for months or even years after starting Benicar. In some cases, patients were misdiagnosed as having Celiac disease (gluten allergy) and continued to suffer for years before doctors realized that Benicar was to blame.
Symptoms of sprue-like enteropathy typically include chronic, watery diarrhea up to 20 times per day. It can lead to dehydration, malnutrition, life-threatening weight-loss, and nausea. Unless Benicar is discontinued, the patient can develop villous atrophy, a permanent type of intestinal damage.
Do I have a Benicar Lawsuit?
The Schmidt Firm, PLLC is currently accepting Benicar induced injury cases in all 50 states. If you or somebody you know has been diagnosed with sprue-like enteropathy, you should contact our lawyers immediately for a free case consultation. Please use the form below to contact our Defective Drug Litigation Group or call toll free 24 hours a day at (866) 920-0753.
Attention Lawyers: We consider a referral from another law firm to be one of the greatest compliments. If your firm is interested in referring us a case or for us to send you a list of previous award judgments and/or average referral fees, please visit the Lawyer Referral section of our website.